Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1
about
Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertasesFunctional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomainInfectivities of human and other primate lentiviruses are activated by desialylation of the virion surfaceHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchThe HIV glycan shield as a target for broadly neutralizing antibodiesOccurrence of an HIV-1 gp160 endoproteolytic activity in low-density vesicles and evidence for a distinct density distribution from endogenously expressed furin and PC7/LPC convertasesCell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 EnvelopeCystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cellsFangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processingEffects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinInhibition of murine leukemia virus envelope protein (env) processing by intracellular expression of the env N-terminal heptad repeat regionN-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropismIdentification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expressionInfluence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum.Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins.Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposureIdentification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processingSpecificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation.The transmembrane glycoprotein of human immunodeficiency virus type 1 induces syncytium formation in the absence of the receptor binding glycoprotein.Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivityInhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein.Bitter-sweet symphony: glycan-lectin interactions in virus biology.Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis.Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein.V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation.Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins.
P2860
Q24534205-931BC2EB-0890-4CAC-9736-B14F0DD0B07CQ24645233-738F2D50-609D-4DC1-AC11-556998A12425Q24680171-76F160E5-6502-49FE-8DF0-0F55CAAFFE96Q26746070-C2DBD1C7-95CC-4470-8A61-EC6AAE3F8F58Q26786540-5BF4D3F9-E619-4B8D-8CC3-21F1732CB21DQ28142392-8F9598C0-5490-437A-8A3C-239A98CC9D47Q28263655-29636562-257C-4041-9AF0-75115AB2C20DQ28369684-6A0EBC9A-25AA-4CEF-AD56-A9CA8E6CBB42Q28480389-7796DB56-8A0B-4AAA-8CF3-7D58E6DF8BBCQ28646850-12E32AFD-800C-4970-A579-5D7EE626D99FQ33724327-B1602D52-7044-4F95-8C02-93AD62607E41Q33842455-0F30C166-EFCA-4436-AF02-66DA88B523D9Q33851952-671E80A7-30A2-4CCC-B35C-177F09F91EA2Q33933098-A361EBDA-B4B5-4834-A1C8-27471E6EFCBDQ34441056-B1C53677-7D19-4289-9660-67CE0B2C372EQ34451461-5985B81E-919B-4A87-9407-D3B7C8C69CAFQ34546037-33920375-FDC9-4DAA-8C68-CC159F4B2112Q34998032-664A25ED-C2D2-46DE-A547-7F0271FA0845Q35851143-5E2D51B9-C51E-4903-92F3-FB51368C132CQ35870879-658109A0-29EF-409B-A091-1E3F508D10F4Q35870903-584D3504-7B63-4939-834B-9E24934072C0Q36094966-CE2BF72B-B0D8-4526-BF5F-060B3C3B6C0CQ36644697-C3BFF8A5-9625-4487-AFAF-34425EEA8A96Q36664069-402625E7-F81F-4DE7-8FE4-95D79009475CQ36669879-54544581-38D8-4F7B-8808-FA768659772EQ36681510-4D1FBCF4-4C71-45E6-B0CE-673B19CF8639Q36698775-F8B301E8-5E6B-4822-8137-B3F70DDF5775Q36822708-DE92081A-440E-46C0-A909-325A29440E5CQ36827782-E200A279-0647-4BC4-9281-243F2111A3A3Q37530422-C088211A-429B-4E6C-9899-659DF8092110Q37649155-2A9D3BAB-54AD-4397-8B50-34E1A1629EA0Q38159719-C75305C3-9500-4A79-AB5E-4C66872D9E9FQ39544233-9A4DB577-227F-4F9F-8B4C-B54CD1BABCECQ39581340-F49E1FAD-039F-48CD-A291-6FEFBD69D35EQ39592261-9EDFDDFB-DB92-43E6-90D8-E63D7AF14D22Q39594428-17D3D586-8B6D-4E2F-A2FA-A74B638E3BADQ39725329-83B4C92F-5CB2-4F55-B6D8-58CF6554A18CQ39871743-9933FAFB-39B6-462E-8DFE-8598CFFFCE57Q40063976-705E108A-9A74-4B1C-8519-2DD0564325D1Q40101656-39BE69A4-3609-41D0-BE30-3C065A9A4832
P2860
Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@ast
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@en
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@nl
type
label
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@ast
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@en
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@nl
prefLabel
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@ast
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@en
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@nl
P2093
P2860
P356
P1476
Role of oligosaccharides in th ...... immunodeficiency virus type 1
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.9.3384
P407
P577
1989-05-01T00:00:00Z